Inspire Medical Systems (INSP) raises guidance

Inspire Medical Systems (NYSE: INSP) raised its revenue forecast for the full year.

The company expects revenue $788 million to $798 million, saw $783 million to $793 million, estimate $788 million.

Prelim Q2 revenue $195.9 million, estimate $186.4 million

You May Also Be Interested In

• Sanuwave Q2 2026 revenue tops revised guidance range
• Health Canada authorizes Dexcom G7 15 Day CGM for Canadian adults
• Gyre Therapeutics (GYRE) files for 31.03M share offering by selling stockholders